The CDC published their second and updated version of their Opioid and Pain Guidelines?
Dr. Chou, one the leading authors discusses what is new to the guidelines.
Roger Chou, MD, is Professor of Medicine and Medical Informatics and Clinical Epidemiology, OHSU, and the Pacific Northwest EPC Director. Dr. Chou’s is trained in internal medicine and is internationally recognized as an expert in opioids and pain. Dr. Chou has led over 70 systematic reviews, including numerous reviews on pain, opioids, overdose prevention, and addiction. Dr. Chou has also conducted primary research on opioids. His reviews were used to develop the 2016 CDC opioid guideline and other high-impact guidelines in this area. He served on the Steering Committee for the 2016 CDC guideline, an NIH-convened research task force for low back pain, an NIH work group to inform the Federal Pain Research Strategy, a federal interagency work group on reducing adverse events associated with opioids, and a CDC opioid prescribing estimates workgroup. He served on a National Academies of Science, Engineering and Medicine committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain, serves on the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, was Coordinating Editor of the Cochrane Back and Neck Group and is now a Senior Editor of the Cochrane Musculoskeletal Group, and is on the Board of Scientific Counselors for the CDC’s National Center for Injury Prevention and Control. He also serves as the methodologist for a number of past, and current, World Health Organization guideline development efforts.